An update from Petros Pharmaceuticals ( (PTPI) ) is now available.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Petros Pharmaceuticals has amended its employment agreement with President Fady Boctor, allowing him to engage in other consulting roles, provided no conflicts arise. The amendment also adjusts his salary to $280,000 annually and sets the employment term to end on December 31, 2024. This move could signal strategic adjustments within the company’s leadership structure.
Find detailed analytics on PTPI stock on TipRanks’ Stock Analysis page.